ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,821, issued on Nov. 11, was assigned to Novartis AG (Basel, Switzerland).
"Antiviral pyridopyrazinedione compounds" was invented by Christopher Becker (Pleasant Hill, Calif.), Xiaolin Li (Alameda, Calif.), Peichao Lu (Pleasant Hill, Calif.), Naomi Samadara Rajapaksa (Fremont, Calif.), David Charles Tully (Danville, Calif.), Xiaojing Michael Wang (Livermore, Calif.) and Qian Zhao (Louisville, Colo.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compounds of Formula (I)as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salt...